Here are the DEF 14A proxy statements from Alignment Healthcare, Inc. (ALHC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ALHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALHC filings page.
Alignment Healthcare, Inc. has released its 2026 proxy statement, inviting stockholders to a virtual annual meeting on June 4, 2026, and seeking votes on three items: election of three Class II directors, ratification of Deloitte as auditor and a non-binding say-on-pay vote.
The proxy highlights 2025 performance, including revenue of $3.9 billion, up 46.1% year over year, health plan membership of 236,300 (up 25.0%), adjusted EBITDA of $109.9 million with a 2.8% adjusted EBITDA margin and a net loss of $1.0 million. All members were in plans rated at least 4 Stars for a second year.
The Board stresses strong governance and compensation practices: 7 of 9 directors are independent, there is a separate chair and CEO with a lead independent director, and a pay-for-performance program where most executive pay is variable, using annual cash incentives and a mix of RSUs and PSUs tied to revenue, adjusted gross profit, adjusted EBITDA and CMS Star Ratings.